II
WST icon

Inspire Investing’s West Pharmaceutical WST Stock Holding History

Inspire Investing’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.71M Buy
13,120
+634
+5% +$194K 0.19% 104
2026
Q1 		$3.13M Buy
12,486
+3,736
+43% +$930K 0.18% 119
2025
Q4 		$2.41M Buy
8,750
+248
+3% +$67.8K 0.22% 118
2025
Q3 		$2.23M Sell
8,502
-603
-7% -$147K 0.22% 120
2025
Q2 		$1.99M Buy
9,105
+502
+6% +$107K 0.22% 115
2025
Q1 		$1.93M Sell
8,603
-2,240
-21% -$617K 0.23% 121
2024
Q4 		$3.55M Buy
10,843
+91
+0.8% +$28.6K 0.4% 50
2024
Q3 		$3.23M Buy
10,752
+535
+5% +$164K 0.33% 57
2024
Q2 		$3.37M Sell
10,217
-1,761
-15% -$622K 0.39% 49
2024
Q1 		$4.74M Sell
11,978
-1,305
-10% -$483K 0.48% 44
2023
Q4 		$4.68M Buy
13,283
+1,817
+16% +$643K 0.51% 34
2023
Q3 		$4.3M Sell
11,466
-340
-3% -$131K 0.55% 31
2023
Q2 		$4.52M Buy
11,806
+1,687
+17% +$603K 0.55% 31
2023
Q1 		$3.51M Buy
10,119
+425
+4% +$124K 0.45% 49
2022
Q4 		$2.28M Sell
9,694
-1,382
-12% -$327K 0.29% 73
2022
Q3 		$2.73M Buy
11,076
+2,012
+22% +$613K 0.39% 56
2022
Q2 		$2.74M Sell
9,064
-294
-3% -$95.7K 0.36% 55
2022
Q1 		$3.84M Sell
9,358
-255
-3% -$99.8K 0.44% 46
2021
Q4 		$4.51M Sell
9,613
-2,612
-21% -$1.12M 0.52% 46
2021
Q3 		$5.19M Buy
12,225
+9,717
+387% +$4.1M 0.66% 28
2021
Q2 		$901K Buy
2,508
+572
+30% +$189K 0.12% 197
2021
Q1 		$546K Buy
1,936
+711
+58% +$203K 0.08% 256
2020
Q4 		$347K Buy
+1,225
New +$344K 0.08% 368

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Inspire Investing's WST Position: Q2 2026 in Review

Inspire Investing increased its West Pharmaceutical (WST) stake by 5.1% in Q2 2026, buying an estimated $194K and bringing the position to 13,120 shares worth $4.71M. The position accounts for 0.19% of the portfolio, ranked #104.

Inspire Investing first reported a position in WST in Q4 2020 and has held it in 23 quarters since. The position peaked at $5.19M in Q3 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Inspire Investing held 13,120 shares of West Pharmaceutical worth $4.71M as of Q2 2026.
  • Inspire Investing bought 634 West Pharmaceutical shares in Q2 2026, an estimated $194K.
  • West Pharmaceutical made up 0.19% of Inspire Investing's portfolio in Q2 2026, its #104 holding.
  • Inspire Investing first reported a position in West Pharmaceutical in Q4 2020 and has held it in 23 quarters since.
  • Inspire Investing's West Pharmaceutical position peaked at $5.19M in Q3 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.